Safety, Reactogenicity, and Immunogenicity of ZR-202-CoV and ZR-202a-CoV Recombinant Vaccines Compared with Comirnaty®: a Randomized, Observer-Blind, Controlled, Phase 1 Study.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES（2024）
Key words
SARS-CoV-2 recombinant vaccine,Beta variant,Delta variant,Omicron BA.5,Neutralizing antibody,Clinical trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined